Rothschild Investment LLC Syndax Pharmaceuticals Inc Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 70 shares of SNDX stock, worth $1,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 25
180.0%
Holding current value
$1,524
Previous $513,000
162.77%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SNDX
# of Institutions
204Shares Held
88.4MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$172 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$160 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$125 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$104 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$84.7 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.23B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...